Drug company hit with $13 million failure-to-warn verdict 
By:
Sylvia Adcock
Published: December 3, 2010
Tags: Aredia, failure to warn, Novartis, osteonecrosis, product liability, Zometa
A federal jury in North Carolina has returned a verdict of nearly $13 million against pharmaceutical giant Novartis, saying the company failed to adequately warn patients and doctors about the risks of taking the bone-strengthening drugs Zometa and Aredia.
Zometa claims can go forward
By:
Pat Murphy
Published: March 13, 2010
Tags: Aredia, drug litigation, product liability, Zometa
A state presumption in favor of manufacturers does not apply to defeat product liability claims brought by plaintiffs who alleged they suffered severe jaw deterioration after taking the defendant’s bone-strengthening drugs, a U.S. District Court in Tennessee has ruled in denying a motion for summary judgment.
SUBSCRIBERS: Did you receive the new Lawyers USA Weekly Update in your inbox on Monday?
If not, click here to register and learn more now.
